ADVI in the News

Inflation Reduction Act Oncology/biologics Strategic Analytics, Value and Economics

ADVI Health Experts Featured in STAT: Navigating Recent and Upcoming CMS Policy Shifts

Advanced Molecular Diagnostics Devices Digital Therapies Hospital Lab Strategy Oncology/biologics Uncategorized Federal And State Policy

Lindsay Bealor Greenleaf Included in Medtech Dive

Advanced Molecular Diagnostics Devices Digital Therapies Hospital Lab Strategy Oncology/biologics Uncategorized Federal And State Policy

Marc Samuels Featured in Bloomberg

Advanced Molecular Diagnostics Devices Digital Therapies Hospital Lab Strategy Oncology/biologics Uncategorized Federal And State Policy

ADVI Expert Lindsay Bealor Greenleaf Shares Insights with the Wall Street Journal

Oncology/biologics Reimbursement

Dr. Michael Kolodziej Featured In JCO Oncology Practice

Cell and Gene Inflation Reduction Act Oncology/biologics Pharmaceuticals and Biotech Federal And State Policy

Marc Samuels Shares Insight on Important 2024 Regulatory Decisions with Pharma’s Almanac

In this Pharma's Almanac article, ADVI’s Marc Samuels, CEO and president, shares his insights on the most significant regulatory decisions stakeholders should consider as we look ahead to 2024.

Cell and Gene Oncology/biologics Pharmaceuticals and Biotech

ADVI and Mix Talent Present: Cell and Gene with Gamida Cell and Zevra Therapeutics

Cell and Gene Oncology/biologics Pharmaceuticals and Biotech

ADVI and Mix Talent Present: Cell and Gene with BridgeBio and Propel Biosciences

Oncology/biologics Market Access

Private Equity Firms Are Increasingly Targeting Oncology, New Data Show

Oncology/biologics Value-Based-Care

AVBCC 2022 Key Takeaways: The impact of the IRA is beyond impacts to pricing